ThaiPR.NET

Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders

thaipr.net — Mon, 04 Jul 2022 17:00:00 +0700

Octapharma to present new clinical and scientific data from across Octapharma’s haematology and critical care portfolios during the ISTH 2022 Congress Data to be presented in 11 poster presentations and during two Supported Symposia New data from the extensive clinical trial programme with Nuwiq® (simoctocog alfa) to be presented, confirming Nuwiq®‘s efficacy and safety profile The […]

The post Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders appeared first on ThaiPR.NET.

Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress

thaipr.net — Tue, 26 Apr 2022 15:00:00 +0700

As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia (WFH) 2022 World Congress, taking place from May 8 to 11, 2022. This continues Octapharma’s long history of involvement and support of the WFH World Congress and the […]

The post Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress appeared first on ThaiPR.NET.

Octapharma puts a spotlight on the challenges of managing inhibitors in haemophilia A at the 15th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

thaipr.net — Thu, 20 Jan 2022 09:10:59 +0700

The virtual symposium held on Wednesday, February 2, 2022, at 18:00 CET, will tell the story of the Rodriguez family and their two sons with haemophilia A as they navigate the challenges of inhibitor management. The development of inhibitors to replacement factor VIII (FVIII) therapy continues to be a significant concern for people with haemophilia […]

The post Octapharma puts a spotlight on the challenges of managing inhibitors in haemophilia A at the 15th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) appeared first on ThaiPR.NET.

Octapharma’s ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress

thaipr.net — Tue, 06 Jul 2021 08:00:00 +0700

Octapharma announced today that new clinical and scientific findings encompassing their Haematology portfolio, including Nuwiq®, wilate®, octanate® and octanine®F, will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress, taking place on July 17–21, 2021. In addition to two Supported Symposia that will discuss the comprehensive management of patients with haemophilia […]

The post Octapharma’s ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress appeared first on ThaiPR.NET.

Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

thaipr.net — Wed, 24 Feb 2021 08:00:00 +0700

Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. “Simoctocog Alfa (Nuwiq®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the […]

The post Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A appeared first on ThaiPR.NET.